It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Immuno-augmentation therapy (IAT), also called immuno-augmentative or immuno-augmentive therapy, is a cancer treatment aimed at restoring the immune system with injections of a mixture of blood factors.
By the mid-1960s, Burton was making sensational presentations. In 1966, at an American Cancer Society (ACS) seminar for science writers, Burton injected mice with his "unblocking factor." Their tumors shrunk in less than an hour. Although newspaper headlines read "15-Minute Cancer Cure," the medical community was unconvinced. Professional journals refused to publish Burton's papers and he eventually lost his research funding. The American Cancer Society (ACS) placed Burton's IAT on its list of unproven methods.
indications for use as an anaesthetic: Paediatric anaesthesia (as the sole anaesthetic for minor procedures or as an induction agent followed by muscle relaxant and endotracheal intubation) Asthmatics or patients with chronic obstructive airway disease Emergency surgery in field conditions in war zones To supplemnt spinal / epidural anaesthesia / analgesia utilizing low doses
patients have reported vivid hallucinations, "going into other worlds" or "seeing God" while anesthetized, and these unwanted psychological side-effects have reduced the use of ketamine in human medicine
We treated two pediatric patients suffering respiratory failure associated with status asthmaticus. Neither patient responded to maximal bronchodilatory therapy and mechanical ventilation; however, continuous infusion of ketamine (1.0 to 2.5 mg/kg-h) immediately improved airway obstruction. Ketamine appears to increase catecholamine levels and directly relax bronchial smooth muscle. Except for increased secretions during the infusion, our patients showed no immediate or long-term sequelae from ketamine therapy. However, ketamine should only be used for asthmatics whose respiratory failure does not respond to conventional management and mechanical ventilation.